CEFASMA-CV

Double Action, Dependable Cure

10x1x10 Tablets

Pharma

Antibacterial

Product highlights

Dual protection against resistance
Broader coverage than cefuroxime alone
Enhanced efficacy in mixed infections
Reduced relapse rates
Protects cefuroxime from enzymatic breakdown

CEFASMA-CV combines Cefuroxime Axetil 500mg with Potassium Clavulanate 125mg to provide superior antibacterial protection and effective treatment against resistant infections.

Dosage Form

Tablet

Product Name

CEFASMA-CV

Composition

Cefuroxime Axetil 500mg + Potassium Clavulanate 125mg

Therapeutic Segment

Antibiotics / Anti-infectives

Pharmacological Action

Broad-spectrum antibacterial with β-lactamase inhibition

Mechanism

Cefuroxime inhibits bacterial cell wall synthesis, while Potassium Clavulanate acts as a β-lactamase inhibitor protecting cefuroxime from enzymatic degradation.

Key Clinical Benefits

Enhanced efficacy against resistant bacteria
Broader antibacterial coverage
Reduced relapse rates
Better effectiveness in mixed infections

Key Indications

Lower respiratory tract infections
Upper respiratory tract infections
Skin & soft tissue infections
Urinary tract infections
Bone & joint infections

Administration

Oral administration after meals for improved absorption

Recommended Usage

1 tablet twice daily or as prescribed by the physician

Dosage Form

Tablet

Product Name

CEFASMA-CV

Composition

Cefuroxime Axetil 500mg + Potassium Clavulanate 125mg

Therapeutic Segment

Antibiotics / Anti-infectives

Pharmacological Action

Antibiotics / Anti-infectives

Mechanism

Cefuroxime inhibits bacterial cell wall synthesis, while Potassium Clavulanate acts as a β-lactamase inhibitor protecting cefuroxime from enzymatic degradation.

Key Clinical Benefits